Operating Income Summary of Boiron SA

Boiron SA's latest annual operating income in 2023 was 42.29 Million EUR , down -24.25% from previous year.
Boiron SA's latest quarterly operating income in 2024 Q2 was 4.87 Million EUR , down 0.0% from previous quarter.
Boiron SA reported an annual operating income of 55.82 Million EUR in 2022, up 49.15% from previous year.
Boiron SA reported an annual operating income of 37.43 Million EUR in 2021, down -45.34% from previous year.
Boiron SA reported a quarterly operating income of 12.34 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Boiron SA reported a quarterly operating income of 28.28 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Boiron SA (2023 - 2001)

Historical Annual Operating Income of Boiron SA (2023 - 2001)

Year	Operating Income	Operating Income Growth
2023	42.29 Million EUR	-24.25%
2022	55.82 Million EUR	49.15%
2021	37.43 Million EUR	-45.34%
2020	68.47 Million EUR	-5.14%
2019	72.19 Million EUR	-33.41%
2018	108.4 Million EUR	-16.62%
2017	130 Million EUR	-2.92%
2016	133.91 Million EUR	-0.93%
2015	135.17 Million EUR	-7.48%
2014	146.11 Million EUR	0.06%
2013	146.02 Million EUR	80.04%
2012	81.1 Million EUR	27.34%
2011	63.69 Million EUR	-4.43%
2010	66.65 Million EUR	-27.37%
2009	91.76 Million EUR	60.47%
2008	57.18 Million EUR	27.97%
2007	44.68 Million EUR	131.8%
2006	19.27 Million EUR	-21.78%
2005	24.64 Million EUR	-25.81%
2004	33.22 Million EUR	-15.94%
2003	39.52 Million EUR	7.27%
2002	36.84 Million EUR	17.47%
2001	31.36 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	4.87 Million EUR	0.0%
2023 Q2	12.34 Million EUR	0.0%
2023 Q4	28.28 Million EUR	0.0%
2023 FY	42.29 Million EUR	-24.25%
2022 Q2	17.07 Million EUR	0.0%
2022 Q4	38.17 Million EUR	0.0%
2022 FY	55.82 Million EUR	49.15%
2021 FY	37.43 Million EUR	-45.34%
2021 Q4	49.69 Million EUR	0.0%
2021 Q2	-12.26 Million EUR	0.0%
2020 Q2	29.49 Million EUR	0.0%
2020 Q4	38.98 Million EUR	0.0%
2020 FY	68.47 Million EUR	-5.14%
2019 FY	72.19 Million EUR	-33.41%
2019 Q4	62 Million EUR	0.0%
2019 Q2	8.16 Million EUR	0.0%
2018 Q2	34.25 Million EUR	0.0%
2018 FY	108.4 Million EUR	-16.62%
2018 Q4	74.14 Million EUR	0.0%
2017 Q2	43.22 Million EUR	0.0%
2017 Q4	86.78 Million EUR	0.0%
2017 FY	130 Million EUR	-2.92%
2016 FY	133.91 Million EUR	-0.93%
2016 Q2	46.68 Million EUR	0.0%
2016 Q4	87.23 Million EUR	0.0%
2015 Q4	92.37 Million EUR	0.0%
2015 Q2	42.8 Million EUR	0.0%
2015 FY	135.17 Million EUR	-7.48%
2014 Q2	38.1 Million EUR	0.0%
2014 FY	146.11 Million EUR	0.06%
2014 Q4	108 Million EUR	0.0%
2013 Q2	46.67 Million EUR	0.0%
2013 FY	146.02 Million EUR	80.04%
2013 Q4	99.34 Million EUR	0.0%
2012 Q2	20.75 Million EUR	0.0%
2012 FY	81.1 Million EUR	27.34%
2012 Q1	20.75 Million EUR	0.0%
2012 Q3	20.75 Million EUR	0.0%
2012 Q4	32.97 Million EUR	58.88%
2011 Q2	16.92 Million EUR	0.0%
2011 FY	63.69 Million EUR	-4.43%
2011 Q4	20.75 Million EUR	22.66%
2011 Q1	16.92 Million EUR	0.0%
2011 Q3	16.92 Million EUR	0.0%
2010 Q2	16.72 Million EUR	0.0%
2010 FY	66.65 Million EUR	-27.37%
2010 Q4	16.92 Million EUR	1.16%
2010 Q3	16.72 Million EUR	0.0%
2010 Q1	16.72 Million EUR	0.0%
2009 Q2	22.78 Million EUR	0.0%
2009 Q3	22.78 Million EUR	0.0%
2009 Q4	16.72 Million EUR	-26.6%
2009 FY	91.76 Million EUR	60.47%
2009 Q1	22.78 Million EUR	0.0%
2008 FY	57.18 Million EUR	27.97%
2008 Q4	22.78 Million EUR	49.8%
2008 Q3	15.21 Million EUR	0.0%
2008 Q2	15.21 Million EUR	0.0%
2008 Q1	15.21 Million EUR	0.0%
2007 Q3	11.29 Million EUR	0.0%
2007 Q2	11.29 Million EUR	0.0%
2007 Q1	11.29 Million EUR	0.0%
2007 Q4	15.21 Million EUR	34.67%
2007 FY	44.68 Million EUR	131.8%
2006 Q4	11.29 Million EUR	130.57%
2006 Q3	4.89 Million EUR	0.0%
2006 Q2	4.89 Million EUR	0.0%
2006 Q1	4.89 Million EUR	0.0%
2006 FY	19.27 Million EUR	-21.78%
2005 FY	24.64 Million EUR	-25.81%
2005 Q4	4.89 Million EUR	-22.56%
2005 Q3	6.32 Million EUR	0.0%
2005 Q2	6.32 Million EUR	0.0%
2005 Q1	6.32 Million EUR	0.0%
2004 FY	33.22 Million EUR	-15.94%
2004 Q4	6.32 Million EUR	-25.3%
2004 Q3	8.46 Million EUR	0.0%
2004 Q2	8.46 Million EUR	0.0%
2004 Q1	8.46 Million EUR	0.0%
2003 Q4	8.46 Million EUR	32.17%
2003 FY	39.52 Million EUR	7.27%
2003 Q3	6.4 Million EUR	0.0%
2003 Q2	6.4 Million EUR	0.0%
2003 Q1	6.4 Million EUR	0.0%
2002 Q1	5.75 Million EUR	0.0%
2002 FY	36.84 Million EUR	17.47%
2002 Q4	6.4 Million EUR	11.35%
2002 Q3	5.75 Million EUR	0.0%
2002 Q2	5.75 Million EUR	0.0%
2001 FY	31.36 Million EUR	0.0%
2001 Q1	4.92 Million EUR	0.0%
2001 Q2	4.92 Million EUR	0.0%
2001 Q3	4.92 Million EUR	0.0%
2001 Q4	5.75 Million EUR	16.84%
2000 Q4	4.92 Million EUR	0.0%

Peer Operating Income Comparison of Boiron SA

Name	Operating Income	Operating Income Difference
Laboratorios Farmaceuticos Rovi, S.A.	220.25 Million EUR	80.799%
Vetoquinol SA	74.26 Million EUR	43.055%
Valneva SE	-82.08 Million EUR	151.519%
AB Science S.A.	-13.42 Million EUR	414.915%
Nanobiotix S.A.	-26.77 Million EUR	257.922%
PHAXIAM Therapeutics S.A.	-23.66 Million EUR	278.74%
Vivoryon Therapeutics N.V.	-28.83 Million EUR	246.652%
BioSenic S.A.	-7.04 Million EUR	700.71%
ABIVAX Société Anonyme	-127.37 Million EUR	133.201%
Formycon AG	-369 Thousand EUR	11560.705%

Global Stocks Search

Boiron SA (0DTF.L)

Operating Income Summary of Boiron SA

Annual Operating Income Chart of Boiron SA (2023 - 2001)

Historical Annual Operating Income of Boiron SA (2023 - 2001)

Peer Operating Income Comparison of Boiron SA